TLRs, future potential therapeutic targets for RA

Hatem A. Elshabrawy, Abdul E. Essani, Zoltán Szekanecz, David A. Fox, Shiva Shahrara

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

Toll like receptors (TLR)s have a central role in regulating innate immunity and in the last decade studies have begun to reveal their significance in potentiating autoimmune diseases such as rheumatoid arthritis (RA). Earlier investigations have highlighted the importance of TLR2 and TLR4 function in RA pathogenesis. In this review, we discuss the newer data that indicate roles for TLR5 and TLR7 in RA and its preclinical models. We evaluate the pathogenicity of TLRs in RA myeloid cells, synovial tissue fibroblasts, T cells, osteoclast progenitor cells and endothelial cells. These observations establish that ligation of TLRs can transform RA myeloid cells into M1 macrophages and that the inflammatory factors secreted from M1 and RA synovial tissue fibroblasts participate in TH-17 cell development. From the investigations conducted in RA preclinical models, we conclude that TLR-mediated inflammation can result in osteoclastic bone erosion by interconnecting the myeloid and TH-17 cell response to joint vascularization. In light of emerging unique aspects of TLR function, we summarize the novel approaches that are being tested to impair TLR activation in RA patients.

Original languageEnglish
Pages (from-to)103-113
Number of pages11
JournalAutoimmunity Reviews
Volume16
Issue number2
DOIs
Publication statusPublished - Feb 1 2017

Fingerprint

Rheumatoid Arthritis
Toll-Like Receptors
Th17 Cells
Myeloid Cells
Therapeutics
Fibroblasts
Osteoclasts
Innate Immunity
Autoimmune Diseases
Ligation
Virulence
Stem Cells
Endothelial Cells
Joints
Macrophages
Inflammation
T-Lymphocytes
Bone and Bones

Keywords

  • Bone erosion
  • Inflammation
  • M1 macrophages
  • Rheumatoid arthritis (RA)
  • TH-17 cells
  • Toll like receptors (TLR)s

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Elshabrawy, H. A., Essani, A. E., Szekanecz, Z., Fox, D. A., & Shahrara, S. (2017). TLRs, future potential therapeutic targets for RA. Autoimmunity Reviews, 16(2), 103-113. https://doi.org/10.1016/j.autrev.2016.12.003

TLRs, future potential therapeutic targets for RA. / Elshabrawy, Hatem A.; Essani, Abdul E.; Szekanecz, Zoltán; Fox, David A.; Shahrara, Shiva.

In: Autoimmunity Reviews, Vol. 16, No. 2, 01.02.2017, p. 103-113.

Research output: Contribution to journalReview article

Elshabrawy, HA, Essani, AE, Szekanecz, Z, Fox, DA & Shahrara, S 2017, 'TLRs, future potential therapeutic targets for RA', Autoimmunity Reviews, vol. 16, no. 2, pp. 103-113. https://doi.org/10.1016/j.autrev.2016.12.003
Elshabrawy, Hatem A. ; Essani, Abdul E. ; Szekanecz, Zoltán ; Fox, David A. ; Shahrara, Shiva. / TLRs, future potential therapeutic targets for RA. In: Autoimmunity Reviews. 2017 ; Vol. 16, No. 2. pp. 103-113.
@article{35d5b8f6b403488baa8353870648ac52,
title = "TLRs, future potential therapeutic targets for RA",
abstract = "Toll like receptors (TLR)s have a central role in regulating innate immunity and in the last decade studies have begun to reveal their significance in potentiating autoimmune diseases such as rheumatoid arthritis (RA). Earlier investigations have highlighted the importance of TLR2 and TLR4 function in RA pathogenesis. In this review, we discuss the newer data that indicate roles for TLR5 and TLR7 in RA and its preclinical models. We evaluate the pathogenicity of TLRs in RA myeloid cells, synovial tissue fibroblasts, T cells, osteoclast progenitor cells and endothelial cells. These observations establish that ligation of TLRs can transform RA myeloid cells into M1 macrophages and that the inflammatory factors secreted from M1 and RA synovial tissue fibroblasts participate in TH-17 cell development. From the investigations conducted in RA preclinical models, we conclude that TLR-mediated inflammation can result in osteoclastic bone erosion by interconnecting the myeloid and TH-17 cell response to joint vascularization. In light of emerging unique aspects of TLR function, we summarize the novel approaches that are being tested to impair TLR activation in RA patients.",
keywords = "Bone erosion, Inflammation, M1 macrophages, Rheumatoid arthritis (RA), TH-17 cells, Toll like receptors (TLR)s",
author = "Elshabrawy, {Hatem A.} and Essani, {Abdul E.} and Zolt{\'a}n Szekanecz and Fox, {David A.} and Shiva Shahrara",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.autrev.2016.12.003",
language = "English",
volume = "16",
pages = "103--113",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - TLRs, future potential therapeutic targets for RA

AU - Elshabrawy, Hatem A.

AU - Essani, Abdul E.

AU - Szekanecz, Zoltán

AU - Fox, David A.

AU - Shahrara, Shiva

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Toll like receptors (TLR)s have a central role in regulating innate immunity and in the last decade studies have begun to reveal their significance in potentiating autoimmune diseases such as rheumatoid arthritis (RA). Earlier investigations have highlighted the importance of TLR2 and TLR4 function in RA pathogenesis. In this review, we discuss the newer data that indicate roles for TLR5 and TLR7 in RA and its preclinical models. We evaluate the pathogenicity of TLRs in RA myeloid cells, synovial tissue fibroblasts, T cells, osteoclast progenitor cells and endothelial cells. These observations establish that ligation of TLRs can transform RA myeloid cells into M1 macrophages and that the inflammatory factors secreted from M1 and RA synovial tissue fibroblasts participate in TH-17 cell development. From the investigations conducted in RA preclinical models, we conclude that TLR-mediated inflammation can result in osteoclastic bone erosion by interconnecting the myeloid and TH-17 cell response to joint vascularization. In light of emerging unique aspects of TLR function, we summarize the novel approaches that are being tested to impair TLR activation in RA patients.

AB - Toll like receptors (TLR)s have a central role in regulating innate immunity and in the last decade studies have begun to reveal their significance in potentiating autoimmune diseases such as rheumatoid arthritis (RA). Earlier investigations have highlighted the importance of TLR2 and TLR4 function in RA pathogenesis. In this review, we discuss the newer data that indicate roles for TLR5 and TLR7 in RA and its preclinical models. We evaluate the pathogenicity of TLRs in RA myeloid cells, synovial tissue fibroblasts, T cells, osteoclast progenitor cells and endothelial cells. These observations establish that ligation of TLRs can transform RA myeloid cells into M1 macrophages and that the inflammatory factors secreted from M1 and RA synovial tissue fibroblasts participate in TH-17 cell development. From the investigations conducted in RA preclinical models, we conclude that TLR-mediated inflammation can result in osteoclastic bone erosion by interconnecting the myeloid and TH-17 cell response to joint vascularization. In light of emerging unique aspects of TLR function, we summarize the novel approaches that are being tested to impair TLR activation in RA patients.

KW - Bone erosion

KW - Inflammation

KW - M1 macrophages

KW - Rheumatoid arthritis (RA)

KW - TH-17 cells

KW - Toll like receptors (TLR)s

UR - http://www.scopus.com/inward/record.url?scp=85008217212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008217212&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2016.12.003

DO - 10.1016/j.autrev.2016.12.003

M3 - Review article

C2 - 27988432

AN - SCOPUS:85008217212

VL - 16

SP - 103

EP - 113

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 2

ER -